Sanofi Q1 earnings: Altuviiio closing in on blockbuster status, Dupixent sales surgenews2025-04-24T10:19:56+00:00April 24th, 2025|Endpoints News|
Roche Q1 earnings: CEO warns that tariffs could impact dealmakingnews2025-04-24T10:12:53+00:00April 24th, 2025|Endpoints News|
Europe ‘falling behind’ on drug R&D and manufacturing investments: AstraZeneca CEOnews2025-04-23T19:54:01+00:00April 23rd, 2025|Endpoints News|
Vaccine makers stand by their investments despite US headwindsnews2025-04-23T19:35:23+00:00April 23rd, 2025|Endpoints News|
Top pharma companies increased lobbying spend at start of 2025news2025-04-23T18:38:26+00:00April 23rd, 2025|Endpoints News|
With aims to become a ‘generational biotech,’ Zealand Pharma hires Lilly veteran as science chiefnews2025-04-23T13:00:33+00:00April 23rd, 2025|Endpoints News|
FDA asks Novavax for post-marketing data of its Covid vaccine, delaying approvalnews2025-04-23T12:06:09+00:00April 23rd, 2025|Endpoints News|
Repertoire inks autoimmune deal with Genentech as it eyes a return to the clinicnews2025-04-23T11:00:32+00:00April 23rd, 2025|Endpoints News|
Eli Lilly sues four telehealth companies selling compounded tirzepatidenews2025-04-23T09:00:39+00:00April 23rd, 2025|Endpoints News|
Bristol Myers’ schizophrenia drug fails Phase 3 trial for adjunctive treatmentnews2025-04-22T21:17:29+00:00April 22nd, 2025|Endpoints News|
